{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T13:23:20Z","timestamp":1790429000650,"version":"4.1.0"},"reference-count":40,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2019,9,6]],"date-time":"2019-09-06T00:00:00Z","timestamp":1567728000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2019,9,6]],"date-time":"2019-09-06T00:00:00Z","timestamp":1567728000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/501100001807","name":"Funda\u00e7\u00e3o de Amparo \u00e0 Pesquisa do Estado de S\u00e3o Paulo","doi-asserted-by":"publisher","award":["2014\/00984-3"],"award-info":[{"award-number":["2014\/00984-3"]}],"id":[{"id":"10.13039\/501100001807","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003593","name":"Conselho Nacional de Desenvolvimento Cient\u00edfico e Tecnol\u00f3gico","doi-asserted-by":"crossref","award":["2015\/141693-0"],"award-info":[{"award-number":["2015\/141693-0"]}],"id":[{"id":"10.13039\/501100003593","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ann Hematol"],"published-print":{"date-parts":[[2019,11]]},"DOI":"10.1007\/s00277-019-03792-x","type":"journal-article","created":{"date-parts":[[2019,9,6]],"date-time":"2019-09-06T17:50:59Z","timestamp":1567792259000},"page":"2507-2521","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":43,"title":["Red blood cells microparticles are associated with hemolysis markers and may contribute to clinical events among sickle cell disease patients"],"prefix":"10.1007","volume":"98","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2564-3064","authenticated-orcid":false,"given":"Oladele Simeon","family":"Olatunya","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carolina","family":"Lanaro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana Leda","family":"Longhini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carla Fernanda Franco","family":"Penteado","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kleber Y.","family":"Fertrin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adekunle","family":"Adekile","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sara T. O.","family":"Saad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fernando Ferreira","family":"Costa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,9,6]]},"reference":[{"key":"3792_CR1","doi-asserted-by":"publisher","first-page":"2018","DOI":"10.1016\/S0140-6736(10)61029-X","volume":"376","author":"DC Rees","year":"2010","unstructured":"Rees DC, Williams TN, Gladwin MT (2010) Sickle-cell disease. Lancet. 376:2018\u20132031","journal-title":"Lancet."},{"key":"3792_CR2","doi-asserted-by":"publisher","first-page":"1561","DOI":"10.1056\/NEJMra1510865","volume":"376","author":"FB Piel","year":"2017","unstructured":"Piel FB, Steinberg MH, Rees DC (2017) Sickle cell disease. N Engl J Med 376:1561\u20131573","journal-title":"N Engl J Med"},{"key":"3792_CR3","doi-asserted-by":"publisher","first-page":"e18010","DOI":"10.1038\/nrdp\/2018.10","volume":"4","author":"GJ Kato","year":"2018","unstructured":"Kato GJ, Piel FB, Reid CD, Gaston MH, Ohene-Frempong, Krishnamurti L, Smith WR, Panepinto JA, Weatherall DJ, Costa FF, Vichinsky EP (2018) Sickle cell disease. Nat Rev Dis Primers 4:e18010. \nhttps:\/\/doi.org\/10.1038\/nrdp\/2018.10","journal-title":"Nat Rev Dis Primers"},{"issue":"8","key":"3792_CR4","doi-asserted-by":"publisher","first-page":"795","DOI":"10.1002\/ajh.23232","volume":"87","author":"MH Steinberg","year":"2012","unstructured":"Steinberg MH, Sebastiani P (2012) Genetic modifiers of sickle cell disease. Am J Hematol 87(8):795\u2013803","journal-title":"Am J Hematol"},{"issue":"1","key":"3792_CR5","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1016\/j.blre.2006.07.001","volume":"21","author":"GJ Kato","year":"2007","unstructured":"Kato GJ, Gladwin MT, Steinberg MH (2007) Deconstructing sickle cell disease:reappraisal of the role of hemolysis in the development of clinical phenotype. Blood Rev 21(1):37\u201347","journal-title":"Blood Rev"},{"issue":"3","key":"3792_CR6","doi-asserted-by":"publisher","first-page":"750","DOI":"10.1172\/JCI89741","volume":"127","author":"GJ Kato","year":"2017","unstructured":"Kato GJ, Steinberg MH, Gladwin MT (2017) Intravascular hemolysis and the pathophysiology of sickle cell disease. J Clin Investig 127(3):750\u2013760","journal-title":"J Clin Investig"},{"key":"3792_CR7","doi-asserted-by":"publisher","first-page":"1195","DOI":"10.1002\/ajh.24562","volume":"91","author":"CT Quinn","year":"2016","unstructured":"Quinn CT, Smith EP, Arbabi S, Khera PK, Lindsel CJ, Niss O, Joiner CH, Franco RS, Cohen RM (2016) Biochemical surrogate markers of hemolysis do not correlate with directly measured erythrocyte survival in sickle cell anemia. Am J Hematol 91:1195\u20131201","journal-title":"Am J Hematol"},{"issue":"24","key":"3792_CR8","doi-asserted-by":"publisher","first-page":"3689","DOI":"10.1182\/blood-2014-03-563874","volume":"123","author":"MT Gladwin","year":"2014","unstructured":"Gladwin MT, Ofori-Acquah SF (2014) Erythroid DAMPs drive inflammation in SCD. Blood 123(24):3689\u20133690","journal-title":"Blood"},{"issue":"3","key":"3792_CR9","doi-asserted-by":"publisher","first-page":"464","DOI":"10.3324\/haematol.2012.068965","volume":"98","author":"M Nouraie","year":"2013","unstructured":"Nouraie M, Lee JS, Zhang Y, Kanias T, Zhao X, Xiong Z, Oriss TB, Zeng Q, Kato GJ, Gibbs SR, Hildesheim ME, Sachdev V, Barst RJ, Machado RF, Hassel KL, Little JA, Schraufnagel DE, Krishnamurti L, Novelli E, Girgis RE, Morris CR, Rosenzweig EB, Badesch DB, Lanzkron S, Castro OL, Goldsmith JC, Gordeuk VR, Glawin MT (2013) The relationship between the severity of hemolysis, clinical manifestations and risk of death in 415 patients with sickle cell anemia in the US and Europe. Haematologica 98(3):464\u2013472","journal-title":"Haematologica"},{"issue":"5","key":"3792_CR10","doi-asserted-by":"publisher","first-page":"811","DOI":"10.1182\/blood.V32.5.811.811","volume":"35","author":"U Muller-Eberhard","year":"1968","unstructured":"Muller-Eberhard U, Javid J, Liem HH, Hanstein A, Hanna M (1968) Plasma concentration of hemopexin, haptogloin, and heme in patients with various hemolytic diseases. Blood 35(5):811\u2013815","journal-title":"Blood"},{"issue":"6","key":"3792_CR11","doi-asserted-by":"publisher","first-page":"2279","DOI":"10.1182\/blood-2005-06-2373","volume":"107","author":"GJ Kato","year":"2006","unstructured":"Kato GJ, McGowan V, Machado RF, Little JA, Taylor J, Morris CR, Nicholas JS, Wang X, Poliakovich M, Morris SM, Gladwin MT (2006) Lactate dehydrogenase as a biomarker of hemolysis-associated nitric oxide resistance, priapism, leg ulceration, pulmonary hypertension, and death in patients with sickle cell disease. Blood 107(6):2279\u20132285","journal-title":"Blood"},{"issue":"24","key":"3792_CR12","doi-asserted-by":"publisher","first-page":"3821","DOI":"10.1182\/blood-2015-04-641522","volume":"125","author":"G Mecabo","year":"2015","unstructured":"Mecabo G, Yamamoto M, Biassi TP, Figueiredo MS (2015) Lactate dehydrogenase isoenzymes 3 and hemolysis in sickle cell anemia a possible correlation. Blood 125(24):3821\u20133822","journal-title":"Blood"},{"key":"3792_CR13","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1182\/blood-2012-10-462135","volume":"121","author":"SK Ballas","year":"2013","unstructured":"Ballas SK (2013) Lactate dehydrogenase and hemolysis in sickle cell disease. Blood 121:243\u2013244","journal-title":"Blood"},{"key":"3792_CR14","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1111\/bjh.14112","volume":"174","author":"RP Hebbel","year":"2016","unstructured":"Hebbel RP, Key NS (2016) Microparticles in sickle cell anemia:promise and pitfalls. Br J Haematol 174:16\u201329. \nhttps:\/\/doi.org\/10.1111\/bjh.14112","journal-title":"Br J Haematol"},{"key":"3792_CR15","doi-asserted-by":"publisher","first-page":"319","DOI":"10.3233\/CH-189014","volume":"68","author":"M Romana","year":"2018","unstructured":"Romana M, Connes P, Nigel SK (2018) Microparticles in sickle cell disease. Clin Hemorheol Microcirc 68:319\u2013329. \nhttps:\/\/doi.org\/10.3233\/CH-189014","journal-title":"Clin Hemorheol Microcirc"},{"key":"3792_CR16","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1016\/j.bcmd.2016.04.003","volume":"59","author":"M Westerman","year":"2016","unstructured":"Westerman M, Porter JB (2016) Red blood cell \u2013derived microparticles: an overview. Blood Cells Mol Dis 59:134\u2013139","journal-title":"Blood Cells Mol Dis"},{"issue":"24","key":"3792_CR17","doi-asserted-by":"publisher","first-page":"3805","DOI":"10.1182\/blood-2014-07-589283","volume":"125","author":"SM Camus","year":"2015","unstructured":"Camus SM, De Moraes JA, Bonnin P, Abyad P, Le Jeun S, Lionnet F, Loufrani I, Grimaud L, Lambry JC, Charue D, Kiger L, Renard JM, Larroque Cle Clesiau H, Tedgui A, Bruneval P, Barja-Fidalgo C, Alexandro A, Theraux PI, Boulanger CM, Blanc-Brude OP (2015) Circulating cell membrane microparticles transfer heme to endothelia cells and trigger vaso-occlussions in sickle cell disease. Blood 125(24):3805\u20133814","journal-title":"Blood"},{"issue":"5","key":"3792_CR18","doi-asserted-by":"publisher","first-page":"e0177397","DOI":"10.1371\/journal.pone.0177397","volume":"12","author":"Y Garnier","year":"2017","unstructured":"Garnier Y, Ferdinand S, Etienne-Julian M, Elana G, Petras M, Doundo L, Tresslere B, Lalanne-Mistrih M, Hardy-Dessources D, Connes P, Romana M (2017) Differences of microparticles patterns between sickle cell anemia and hemoglobin SC patients. PLoS ONE 12(5):e0177397. \nhttps:\/\/doi.org\/10.1371\/journal.pone.0177397","journal-title":"PLoS ONE"},{"issue":"7","key":"3792_CR19","doi-asserted-by":"publisher","first-page":"663","DOI":"10.1002\/cyto.a.22892","volume":"89","author":"Lukas Wisgrill","year":"2016","unstructured":"Wisgrill L, Lamm C, Hartmann J, Preibing F, Dragosits K, Bee A, Hell L, Thaler J, Ay C, Pabinger I, Berger A, SPittler A. (2016) Cytometry part a. 89A:663\u2013672","journal-title":"Cytometry Part A"},{"key":"3792_CR20","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1002\/ajh.21750","volume":"85","author":"SK Ballas","year":"2010","unstructured":"Ballas SK, Lieff S, Benjamin LJ, Dampier CD, Heeney MM, Hope C, Johnso CS, Rogers ZR, Smith-Whitley K, Wang MC, Teley MJ (2010) Definitions of the phenotypic manifestations of sickle cell disease. Am J Hematol 85:6\u201313","journal-title":"Am J Hematol"},{"issue":"6","key":"3792_CR21","doi-asserted-by":"publisher","first-page":"831","DOI":"10.1002\/pbc.23399","volume":"58","author":"GJ Kato","year":"2012","unstructured":"Kato GJ (2012) TRV: a physiological biomarker in sickle cell disease. Pediatr Blood Cancer 58(6):831\u2013832","journal-title":"Pediatr Blood Cancer"},{"issue":"9","key":"3792_CR22","doi-asserted-by":"publisher","first-page":"E520","DOI":"10.10002\/ajh.24810","volume":"92","author":"CT Quin","year":"2017","unstructured":"Quin CT, Saraf SL, Gordeuk VR, Fitzhugh CD, Creary SE, Bodas P, George A, Raj A, Nero AC, Terrell CE, McCord L, Lane A, Ackerman HA, Yang Y, Niss O, Taylor MD, Devarajan P, Malik P (2017) Losartan for the nephropathy of sickle cell anemia: a phase-2, multicentre trial. Am J Hematol 92(9):E520\u2013E528. \nhttps:\/\/doi.org\/10.10002\/ajh.24810","journal-title":"Am J Hematol"},{"key":"3792_CR23","doi-asserted-by":"publisher","first-page":"428","DOI":"10.1001\/archopht.1971.00990050430006","volume":"85","author":"MF Goldberg","year":"1971","unstructured":"Goldberg MF (1971) Natural history of untreated proliferative sickle retinopathy. Arch Opthalmol 85:428\u2013437","journal-title":"Arch Opthalmol"},{"key":"3792_CR24","doi-asserted-by":"publisher","first-page":"2215","DOI":"10.1182\/blood-2016-12-755777","volume":"130","author":"M Dubert","year":"2017","unstructured":"Dubert M, Elion J, Tolo A, Diallo DA, Diop S, Diagne I, Sanogo I, Belinga S, Guito O, Wamba G, Sack FN, Boidy K, Kamara I, Traore Y, Diakite CO, Gbonon V, Faye BF, Seck M, Deme I, Chelo D, N\u2019Guetta R, Diop IB, Gaye B, Xavier J, Ranque B (2017) Degree of anemia, indirect markers of hemolysis, and vascular complications of sickle cell disease. Blood 130:2215\u20132223","journal-title":"Blood"},{"key":"3792_CR25","doi-asserted-by":"publisher","first-page":"705","DOI":"10.1002\/ajh.22065","volume":"86","author":"CP Minniti","year":"2011","unstructured":"Minniti CP, Taylor JG, Hildesheim M, O\u2019Neal P, Wilson J, Castro O, Gordeuk V, Kato GJ (2011) Laboratory and echocardiography markers in sickle cell patients with leg leg ulcers. Am J Hematol 86:705\u2013708","journal-title":"Am J Hematol"},{"key":"3792_CR26","doi-asserted-by":"publisher","first-page":"687","DOI":"10.1182\/blood-2010-02-268193","volume":"116","author":"HF Bun","year":"2010","unstructured":"Bun HF, Nathan DG, Dover GJ, Hebbel RP, Platt OS, Rose WF (2010) Pulmonary hypertension and nitric oxide depletion in sickle cell disease. Blood 116:687\u2013692","journal-title":"Blood"},{"key":"3792_CR27","doi-asserted-by":"publisher","first-page":"1513","DOI":"10.3324\/haematol.2009.008938","volume":"94","author":"EJ van Beers","year":"2009","unstructured":"van Beers EJ, Schaap MC, Berckmans RJ, Nieulawland R, Sturk A, vanDoormaal FF, Meijers JC, Biemond BJ (2009) Circulating erthrocyte derived microparticles are associated with coagulation activatioln in sickle cell disease. Haematologica 94:1513\u20131519","journal-title":"Haematologica"},{"key":"3792_CR28","doi-asserted-by":"publisher","first-page":"1119","DOI":"10.1182\/blood.V96.3.1119","volume":"96","author":"BN Setty","year":"2000","unstructured":"Setty BN, Kulkarni S, Rao AK, Stuart MJ (2000) Fetal hemoglobin in sickle cell disease:relationship to erythrocyte phosphatidylserine exposure and coagulation activation. Blood 96:1119\u20131124","journal-title":"Blood"},{"key":"3792_CR29","doi-asserted-by":"publisher","first-page":"1044","DOI":"10.1160\/TH11-10-0689","volume":"107","author":"GT Gerotziafas","year":"2012","unstructured":"Gerotziafas GT, Van Dreden P, Chaari M, Galea V, Khartechi A, Lionnet F, Stanovic-Stojanovic K, Blanc-Brude O, Woodhams B, Maier-Redelsperger M, Girot R, Hatmi M, Elalamy I (2012) The acceleration of the propagation phase of thrombin generation in patients with steady state sickle cell disease is associated with circulating erythrocyte \u2013derived microparticles. Thromb Haemost 107:1044\u20131052","journal-title":"Thromb Haemost"},{"issue":"6","key":"3792_CR30","doi-asserted-by":"publisher","first-page":"862","DOI":"10.3324\/haematol.2012.073619","volume":"98","author":"D Nebor","year":"2013","unstructured":"Nebor D, Romana M, Santiago R, Vachiery N, Picot J, Broquere C, Chaar V, Doumdo L, Odievre M, Benkerrou M, Elion J (2013) Fetal hemoglobin and hydroxy carbamide modulate both plasma concentration and cellular origin of circulating microparticles in sickle cell anemia children. Haematologica 98(6):862\u2013867","journal-title":"Haematologica"},{"key":"3792_CR31","doi-asserted-by":"publisher","first-page":"28414","DOI":"10.3402\/jev.v4.28414","volume":"4","author":"A Piccin","year":"2015","unstructured":"Piccin A, Murphy C, Eakins E, Kunde J, Corvetta D, Di-Pierro A, Negri G, Guido M, Sainati I, McMahon C, Smith OP, Murphy W (2015) Circulating microparticles , protein C, free protein S, and enndothelial vascular markers in children with sickle cell anemia. J Extracell Vesicles 4:28414","journal-title":"J Extracell Vesicles"},{"key":"3792_CR32","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1159\/000362148","volume":"133","author":"DM Brunetta","year":"2015","unstructured":"Brunetta DM, De Santis GC, Silva-Pinto AC, Olivera de Olivera LC, Covas DT (2015) Hydroxyurea increases plasma concentrations of microparticles and reduces coagulation activation and fibrinolysis in patients with sickle cell anemia. Acta Haematol 133:287\u2013294","journal-title":"Acta Haematol"},{"key":"3792_CR33","doi-asserted-by":"publisher","first-page":"1164","DOI":"10.1016\/j.freeradbiomed.2013.09.002","volume":"65","author":"C Liu","year":"2013","unstructured":"Liu C, Zhao W, Christ GJ, Gladwin MT, Kim-Shapiro DB (2013) Nitric oxide scavenging by red cell microparticles. Free Radic Biol Med 65:1164\u20131173","journal-title":"Free Radic Biol Med"},{"key":"3792_CR34","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1183\/09031936.00134410","volume":"39","author":"GHH Fonseca","year":"2012","unstructured":"Fonseca GHH, Souza R, Salemi VMC, Jardim CVP, Gualandro SFM (2012) Pulmonary hypertension diagnosed by right heart catherisation in sickle cell disease. Eur Respir J 39:112\u2013118","journal-title":"Eur Respir J"},{"issue":"11","key":"3792_CR35","doi-asserted-by":"publisher","first-page":"1549","DOI":"10.3324\/haematol.11576","volume":"92","author":"RI Liem","year":"2007","unstructured":"Liem RI, Young LT, Thompson AA (2007) Triscupid regurgitant jet velocity is associated with hemolysis in children and young adults with sickle cell evaluated for pulmonary hypertension. Haematologica 92(11):1549\u20131552","journal-title":"Haematologica"},{"issue":"8","key":"3792_CR36","doi-asserted-by":"publisher","first-page":"840","DOI":"10.1164\/rccm.201207-1222OC","volume":"187","author":"A Mehari","year":"2013","unstructured":"Mehari A, Alam S, Tian X, Cuttical MJ, Barnett CF (2013) Hemodynamic predictors of mortality in adults with sickle cell disease. Am J Respir Crit Care Med 187(8):840\u2013847","journal-title":"Am J Respir Crit Care Med"},{"key":"3792_CR37","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1056\/NEJMoa1005565","volume":"365","author":"F Parent","year":"2011","unstructured":"Parent F, Bachir D, Inamo J, Lionnel F, Driss F (2011) A hemodynamic study of pulmonary hypertension in sickle cell disease. N Engl J Med 365:44\u201353","journal-title":"N Engl J Med"},{"issue":"12","key":"3792_CR38","doi-asserted-by":"publisher","first-page":"1254","DOI":"10.1001\/jama.2012.358","volume":"307","author":"A Mehari","year":"2012","unstructured":"Mehari A, Gladwin MT, Tian X, Machado RF, Kato GJ (2012) Mortality in adults with sickle cell disease and pulmonary hypertension. J Am Med Assoc 307(12):1254\u20131256","journal-title":"J Am Med Assoc"},{"issue":"3","key":"3792_CR39","doi-asserted-by":"publisher","first-page":"1123","DOI":"10.1016\/j.jacc.2011.10900","volume":"59","author":"MT Gladwin","year":"2012","unstructured":"Gladwin MT, Sachdev V (2012) Cardiovascular abnormalities in sickle cell disease. J Am Coll Cardiol Img 59(3):1123\u20131133. \nhttps:\/\/doi.org\/10.1016\/j.jacc.2011.10900","journal-title":"J Am Coll Cardiol Img"},{"issue":"8","key":"3792_CR40","doi-asserted-by":"publisher","first-page":"605","DOI":"10.3109\/09537104.2012.749397","volume":"24","author":"AA Tantawy","year":"2013","unstructured":"Tantawy AA, Adly AA, Ismail EA, Habeeb NM, Farouk A (2013) Circulating platelet and erythrocyte microparticles in young children and adolescents with sickle cell disease: relation to cardiovascular complications. Platelets 24(8):605\u2013614","journal-title":"Platelets"}],"container-title":["Annals of Hematology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00277-019-03792-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00277-019-03792-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00277-019-03792-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,9,4]],"date-time":"2020-09-04T23:09:03Z","timestamp":1599260943000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00277-019-03792-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,9,6]]},"references-count":40,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2019,11]]}},"alternative-id":["3792"],"URL":"https:\/\/doi.org\/10.1007\/s00277-019-03792-x","relation":{},"ISSN":["0939-5555","1432-0584"],"issn-type":[{"value":"0939-5555","type":"print"},{"value":"1432-0584","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,9,6]]},"assertion":[{"value":"7 April 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 August 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 September 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The study was conducted according to the international standards of biomedical and human research. The study was approved by the institutional review board of UNICAMP no. CAAE 54031115.9.0000.5404, and written informed consent was obtained from all participants before being included in the study.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}